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Background: Sarcoidosis is an idiopathic multisystem disease characterized by noncaseating 
granulomatous inflammation. Renal biopsy is often performed to evaluate the patient with sar-
coidosis and acute kidney injury (AKI). Diagnosis rests on the demonstration of noncaseating 
granulomas and exclusion of other causes of granulomatous inflammation. This paper reports 
a patient with pulmonary sarcoidosis and AKI whose renal function improved after prednisone 
therapy despite the absence of kidney biopsy findings characteristic of sarcoidosis.
Case report: A 63-year-old Caucasian male with history of hypertension was treated for 
  pulmonary sarcoidosis with a 6-month course of prednisone. His creatinine was 1.6 mg/dL dur-
ing the course. Two months after finishing treatment, he presented with creatinine of 4 mg/dL. 
A kidney biopsy was performed, which showed nonspecific changes without evidence of 
granuloma or active interstitial inflammation. He was empirically started on prednisone for 
presumed renal sarcoidosis, even with a nondiagnostic kidney biopsy finding. Within a month 
of treatment, his serum creatinine improved to 2 mg/dL, though not to baseline. He continues 
to be stable on low-dose prednisone. With this case as a background, we aimed to determine 
the incidence of inconclusive kidney biopsies in patients with sarcoidosis presenting with AKI 
and to identify the various histological findings seen in this group of patients.
Methods: In this retrospective study, all patients who had native renal biopsies read at The Ohio 
State University over the period of 6 years were identified. Those patients with a diagnosis of 
sarcoidosis, presenting with AKI, were included for further review.
Results: Out of 21 kidney biopsies done in patients with sarcoidosis over a period of 6 years, 
only four (19%) showed granulomatous interstitial nephritis (GIN). An equal number of patients 
(4 [19%]) had presence of membranous nephropathy. Nephrocalcinosis was seen in three 
patients (14%). Almost half of the biopsies had findings suggestive of diabetic nephropathy or 
other nonspecific changes not characteristic of renal sarcoidosis (48%).
Conclusion: Renal sarcoidosis can be focal in nature and characteristic lesions can be missed 
in a small-needle core biopsy. Inconclusive renal biopsies with only nonspecific findings are 
frequent in patients with sarcoidosis and AKI. The presence of GIN on renal biopsy, although 
classic, is uncommon. Renal sarcoidosis remains a presumptive clinical diagnosis and empiric 
treatment with steroids may be initiated in cases with a strong clinical suspicion even in the 
absence of characteristic renal biopsy findings.
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Background
Sarcoidosis is an idiopathic multisystem disease characterized by noncaseating 
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noncaseating granulomas in a biopsy specimen and   clinical 
exclusion of other causes of granulomatous   inflammation. 
Renal involvement is only seen in a small number of 
patients. The incidence of renal sarcoidosis varies widely 
(0.7%–10%), in part due to varying definitions used in 
  different studies.3
Kidney biopsy is often performed to evaluate patients 
with sarcoidosis presenting with acute kidney injury (AKI). 
Besides granulomatous interstitial nephritis (GIN), a variety 
of different histological lesions associated with glomerular 
involvement in sarcoidosis have been described, including 
membranous nephropathy, diffuse proliferative or crescentic 
glomerulonephritis, and focal segmental glomerulosclerosis. 
This demonstrates the need for further diagnostic evaluation 
including a kidney biopsy. However, sampling error is fairly 
common given the focal nature of renal sarcoidosis. Thus, 
a nondiagnostic kidney biopsy in these patients represents 
a major diagnostic and therapeutic dilemma, even in the 
present era.
This paper reports a patient with a history of pulmonary 
sarcoidosis who presented with AKI. Kidney functions 
improved with steroid treatment but rapidly deteriorated 
after completion of the steroid taper. In spite of a non-
diagnostic kidney biopsy, the patient was empirically treated 
with prednisone for presumed renal sarcoidosis. Kidney 
functions improved within a month of prednisone, although 
not back to baseline. He continues to be stable on low-dose 
prednisone. With this case as a background, it is hypothesized 
that although clinicians often perform a kidney biopsy in 
patients with sarcoidosis presenting with AKI, it has limited 
diagnostic utility. A retrospective chart review of patients 
with sarcoidosis presenting with AKI who underwent a native 
kidney biopsy was performed to determine the incidence 
of nondiagnostic kidney biopsies. Those with confirmed 
diagnosis of sarcoidosis according to the statement of the 
American Thoracic Society (ATS) were included.1 For the 
purpose of the study, AKI was defined as an increase in serum 
creatinine of $0.3 mg/dL or an increase to $150%–200% 
(1.5- to 2-fold) from baseline (Acute Kidney Injury Network 
[AKIN] criteria stage I).4
Case report
A 63-year-old Caucasian man was diagnosed with pul-
monary sarcoidosis. Three months before presentation, he 
had developed chest pain, shortness of breath, fatigue, and 
productive cough for which he received multiple antibiotics 
without improvement. His medical history was significant 
for hypertension and was taking amlodipine 5 mg once a 
day. He denied using other over-the-counter medications 
including nonsteroidal anti-inflammatory drugs. Computed 
tomography of the chest showed ground glass opacification 
with a 1.3 cm × 2.1 cm left upper lobe calcified nodule. 
Lung biopsy revealed multiple nonnecrotizing granulomas 
and aggregates of multinucleated giant cells, consistent with 
sarcoidosis. Symptomatic improvement was noted after he 
had taken prednisone 40 mg daily for 2 weeks. This was 
followed by 6 months of prednisone taper. He had normal 
kidney function with serum creatinine of 0.9 mg/dL at the 
time of initial presentation. By the time he was started on 
prednisone, the serum creatinine had increased to 2.2 mg, 
which then improved to 1.6 mg/dL. Two months after finish-
ing the course of prednisone, his creatinine was found to be 
4 mg/dL. He was referred to the nephrology clinic. His serum 
calcium was 9.3 mg/dL (normal range 8.6–10.0 mg/dL) with 
an albumin of 4.1 g/dL (normal range 3.4–4.8 g/dL). Urine 
analysis was unremarkable with a protein:creatinine ratio 
of 30 mg/g of creatinine (normoalbuminuria , 30 mg/g). 
Renal ultrasound showed normal-sized kidneys with no 
hydronephrosis, calculi, or calcification. The autoimmune 
workup, including antinuclear antibodies and antineutrophil 
cytoplasmic antibodies, was negative. Complement levels 
were normal and there was a negative viral hepatitis panel. 
A kidney biopsy was performed to aid the diagnosis.
The biopsy revealed nonspecific findings including mild 
to moderate focal interstitial fibrosis, but there was no evi-
dence of granulomatous inflammation, calcium-phosphate 
deposition or immune complex deposition (Figure 1). On 
electron microscopy, the glomerular basement membrane 
was of normal thickness and texture without podocyte foot 
process effacement.
Figure 1 An area of interstitial fibrosis with mild mononuclear cell inflammation. 
Note the normal glomerulus.
Notes: Stained with hematoxylin-eosin; magnification ×100.International Journal of Nephrology and Renovascular Disease 2011:4 submit your manuscript | www.dovepress.com
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Despite the nonspecific kidney biopsy findings, the 
patient was restarted on prednisone, based on the strong 
clinical suspicion of renal sarcoidosis. His kidney func-
tion improved after restarting the prednisone therapy. 
Figure 2 shows the progression of serum creatinine 
before, during, and after prednisone therapy. Serum crea-
tinine improved to 2 mg/dL within 1 month of treatment, 
though not to baseline. The patient continued to be stable 
on low-dose prednisone. Considering the incongruence 
between the pathological findings and clinical course, and 
remarkable improvement after treatment with steroids, we 
conducted a systematic retrospective review of all kidney 
biopsies done in patients with sarcoidosis and AKI at our 
institution.
Methods
Objectives
The primary objective was to determine the incidence of 
nondiagnostic kidney biopsies in patients with biopsy-proven 
sarcoidosis and AKI. It was also planned to identify the vari-
ous histological findings seen in this group of patients.
Patient selection
In this retrospective study, all patients who had native kidney 
biopsies read at The Ohio State University from January 1, 
2003 to December 31, 2009 were identified. Those patients 
with a diagnosis of sarcoidosis presenting with AKI were 
included for further review.
Kidney biopsy workup
Tissue for light microscopy was fixed in 10%   formalin, 
embedded in paraffin, sectioned (2–3 µm), and stained with 
hematoxylin-eosin, periodic acid–Schiff,   Masson’s trichrome, 
and methenamine silver. For direct   immunofluorescence, the 
tissue was placed in optimal cutting temperature compound 
and snap frozen in liquid nitrogen. Fluorescein isothio-
cyanate–conjugated primary polyclonal rabbit antihuman 
antibodies to immunoglobulin (Ig) G, IgA, IgM, C1q, C3, 
fibrinogen, and κ and λ light chains (all from Dako Cyto-
mation, Carpinteria, CA) were used on frozen sections. The 
intensity of staining was graded on a scale from 0 to 3+ 
(1+, mild staining; 2+, moderate staining; 3+, strong stain-
ing; ±, trace staining). For electron microscopy, tissue was 
fixed in 3% buffered glutaraldehyde (pH 7.4) and postfixed 
in osmium tetroxide. Following routine processing and 
embedding into Spurr resin, thin sections were cut and con-
trasted with uranyl acetate and lead citrate. Ultra  structural 
examination was performed using a Carl Zeiss EM 900 (Carl 
Zeiss AG, Oberkochen, Germany) transmission electron 
microscope.
Results
A total of 2780 native kidney biopsy specimens were read 
during the study period. Out of these, 21 patients with a 
history of biopsy-proven sarcoidosis presented with AKI 
and underwent a native kidney biopsy. Of those, 15 patients 
(71%) were male and six patients (29%) were female with a 
mean age of 55 ± 14.37 years. Fifteen patients were   Caucasian 
(71%) and six (29%) were African American.   Demographics; 
comorbid conditions; laboratory data, including baseline 
creatinine and peak serum creatinine; and a 24-hour urine 
protein excretion are summarized in Table 1.
The histopathological findings of these patients were 
divided into four groups (Table 2). Only four patients (19%) 
showed findings of granulomatous interstitial nephritis (GIN), 
a histopathological hallmark of renal sarcoidosis. An equal 
number of patients (19%) had biopsy findings suggestive of 
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Figure 2 Time course of serum creatinine and prednisone therapy.
Table 1 Patient characteristics
Age (years) (mean ± SD) 55 ± 14.37
gender
  Male 15 (71%)
  Female 6
Race
  caucasian 15 (71%)
  African American 6
comorbid conditions
  hypertension 12 (57%)
  DM 10 (48%)
Laboratory data
  Baseline cr (mg/dL) (mean ± SD) 1.05 ± 0.16
  Peak cr (mg/dL) (Mean ± SD) 2.88 ± 1.85
  Proteinuria (gm/24 hours) (mean ± SD) 4.3 ± 2.33
Abbreviations: cr, creatinine; DM, diabetes mellitus; SD, standard deviation.International Journal of Nephrology and Renovascular Disease 2011:4 submit your manuscript | www.dovepress.com
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either membranous mephropathy or diabetic nephropathy. 
A third of the patients had nonspecific changes characteristic 
of chronic kidney injury. Presence of nephrocalcinosis was 
noted in three patients (14%).
Discussion
Sarcoidosis is an idiopathic multisystem illness character-
ized by granulomatous inflammation, postulated to be an 
autoimmune response to either an infection or an unknown 
environmental agent.1–3 Diagnosis rests on the demonstration 
of characteristic noncaseating granulomas in a biopsy speci-
men of one or more involved organs and clinical exclusion 
of other important causes of granulomatous inflammation.3,4 
Worldwide, sarcoidosis is diagnosed most often at about 
40 years of age and across all ethnicities, although, in the 
USA, African Americans have a tenfold greater incidence 
than Caucasians.5,6
Although it can affect any organ system, according to 
a retrospective registry, involvement of pulmonary, skin, 
lymphatic, and ocular systems was respectively seen in 
95%, 15.9%, 15.2%, and 11.8%.4,7 The true incidence of 
renal sarcoidosis is hard to determine, in part because of 
varying definitions. In the aforementioned series of 736 
patients, the incidence of renal sarcoidosis was 0.7%.4,7 
Although sarcoidosis is primarily a granulomatous inflam-
mation, GIN accounts for only a small proportion of clini-
cally significant kidney failure in patients with sarcoidosis. 
Instead, deranged vitamin D and calcium metabolism 
leading to hypercalcemia, hypercalciuria, nephrolithiasis, 
and nephrocalcinosis are more common problems.8,9 In 
normal subjects, the conversion of 25-hydroxyvitamin D 
to calcitriol occurs via 1-hydroxylase in the kidney. This 
is under the physiologic control of parathyroid hormone 
(PTH), which is suppressed by hypercalcemia. The lack 
of suppression of calcitriol production in sarcoidosis and 
other granulomatous diseases is due to PTH-independent 
extrarenal production of calcitriol from calcidiol by acti-
vated mononuclear cells (particularly macrophages) in 
the lung and lymph nodes.10,11 Furthermore, polyuria is 
often associated with hypercalcemia and hypercalciuria 
due to antidiuretic hormone dysregulation and can cause 
hemodynamically mediated AKI.12–14 Renal tubular defects, 
glomerular diseases, mechanical urinary tract disease, and 
renovascular diseases complete the spectrum of sarcoidosis-
related kidney diseases.3
GIN is a rare histologic diagnosis that is present in 
0.5%–0.9% of native kidney biopsies and 0.6% of kidney 
transplant biopsies.15–17 GIN has been associated with 
medications, infections, sarcoidosis, crystal deposits, 
paraproteinemia, and Wegener’s granulomatosis and can 
also be idiopathic. Only small series and anecdotal reports 
of GIN in sarcoidosis are available in the literature.18,19 
Table 2 Histopathological kidney biopsy findings
Findings Number of patients (n = 21)
granulomatous interstitial nephritis  
(renal sarcoidosis)
4/21 (19%)
Membranous nephropathy 4/21 (19%)
Diabetic nephropathy 4/21 (19%)
Nephrocalcinosis 3/21 (14%)
Nonspecific changes of chronic  
kidney injury
6/21 (29%)
Abbreviation: n, number.
Table 3 Studies evaluating histological findings in patients with renal sarcoidosis
Published Study type N eGFR on presentation 
(mL/min)
eGFR at 1 year  
(mL/min)
Kidney  
biopsy
Histopathological findings Median follow-up 
(months)
Rajakariar  
et al22
Single center 
retrospective  
case series
39 26.8 ± 14 49.6 ± 5.2 20* (51%) TIN: 17/20(86%)
granuloma: 16/20 (80%)
glomerular diseases with  
no TIN:
• Membranous gN: 1
• FSgS: 1
• Minimal change: 1
Intracellular calcifications: 5
84
Mahevas  
et al23
Multicenter 
retrospective  
study
47 20 ± 19 47 ± 19.9 47* (100%) gIN: 37
Interstitial nephritis with no  
gIN: 10
Interstitial calcifications: 8
24
Note: *Tubular atrophy and interstitial fibrosis were seen in all patients.
Abbreviations: N, number of patients; eGFR, estimated glomerular filtration rate; MDRD, modification of diet in kidney disease formula; GIN, granulomatous interstitial 
nephritis; TIN, tubulointerstitial nephritis; FSgS, focal segmental glomerulosclerosis.International Journal of Nephrology and Renovascular Disease 2011:4 submit your manuscript | www.dovepress.com
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A variety of different histological lesions associated with 
glomerular involvement in sarcoidosis have been described, 
including membranous nephropathy, diffuse proliferative 
or crescentic glomerulo  nephritis, and focal segmental 
glomerulosclerosis. The variation demonstrates the impor-
tance of kidney biopsy.20,21
Few studies have evaluated histological findings in 
patients with renal sarcoidosis (Table 3). However, patients 
in these studies already had markedly impaired kidney 
function (chronic kidney disease stage III) on presentation, 
presumably due to renal sarcoidosis. There was significant 
improvement noted in kidney function after prednisone 
treatment. This might explain why the majority of the study 
population showed the presence of tubulointerstitial nephritis 
or GIN (80%).22,23
Patients with sarcoidosis often present with acute kidney 
injury. A kidney biopsy is often performed to aid the diag-
nosis of renal sarcoidosis. As seen in this study, almost half 
of the patients had nonspecific findings, including diabetic 
nephropathy, interstitial fibrosis, and tubular atrophy. Thus, 
the absence of characteristic kidney biopsy findings does 
not exclude the diagnosis of renal sarcoidosis. This was 
a retrospective study done at a single institution, which 
might limit the generalization of our findings. As many of 
the kidney biopsy specimens were sent from various out-
side hospitals, the information provided from the referring 
physicians was relied upon and complete information about 
the treatment and long term follow-up on these patients was 
not available.
Corticosteroids are the cornerstone for sarcoidosis treat-
ment, usually started at the equivalent of prednisone 1 mg/
kg/day.21–24 There is usually an impressive response but 
relapses are frequent, particularly when steroids are tapered. 
These relapses usually respond to reinitiation of steroids, but 
most patients are left with chronic kidney dysfunction from 
interstitial fibrosis.21–24 Patients who are steroid intolerant or 
steroid resistant have been treated with cyclophosphamide, 
infliximab, azathioprine, and mycophenolate mofetil with 
varying degrees of success.25
Conclusion
In patients with sarcoidosis presenting with AKI, clinicians 
often rely on kidney biopsy as a diagnostic tool. However, kid-
ney biopsy findings are often nondiagnostic, perhaps because 
of sampling issues. The absence of kidney biopsy findings 
characteristic of sarcoidosis does not exclude the possibility 
of kidney involvement in the disease. The presence of GIN 
on kidney biopsy, although classic, is uncommon, especially 
during the early stages. This study underscores the limited 
diagnostic utility of kidney biopsy in patients with sarcoidosis 
presenting with AKI. A trial of steroid therapy is warranted 
in patients with strong clinical suspicion of renal sarcoidosis, 
even with a nondiagnostic kidney biopsy.
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